| Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK’s Haematological Malignancy Research Network A Smith, S Crouch, S Lax, J Li, D Painter, D Howell, R Patmore, A Jack, ... British journal of cancer 112 (9), 1575-1584, 2015 | 496 | 2015 |
| A chemical and phosphoproteomic characterization of dasatinib action in lung cancer J Li, U Rix, B Fang, Y Bai, A Edwards, J Colinge, KL Bennett, J Gao, ... Nature chemical biology 6 (4), 291-299, 2010 | 323 | 2010 |
| Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma X Zhao, T Lwin, A Silva, B Shah, J Tao, B Fang, L Zhang, K Fu, C Bi, J Li, ... Nature communications 8 (1), 14920, 2017 | 155 | 2017 |
| Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor–dependent human lung cancer cells A Edwards, J Li, P Atadja, K Bhalla, EB Haura Molecular cancer therapeutics 6 (9), 2515-2524, 2007 | 153 | 2007 |
| A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells J Li, J Viallet, EB Haura Cancer chemotherapy and pharmacology 61, 525-534, 2008 | 152 | 2008 |
| Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non–small cell lung cancer T Yoshida, G Zhang, MA Smith, AS Lopez, Y Bai, J Li, B Fang, J Koomen, ... Clinical Cancer Research 20 (15), 4059-4074, 2014 | 123 | 2014 |
| Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors Y Bai, J Li, B Fang, A Edwards, G Zhang, M Bui, S Eschrich, S Altiok, ... Cancer research 72 (10), 2501-2511, 2012 | 123 | 2012 |
| Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA H Chen, L Teng, JN Li, R Park, DE Mold, J Gnabre, JR Hwu, WN Tseng, ... Journal of medicinal chemistry 41 (16), 3001-3007, 1998 | 109 | 1998 |
| MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion J Gao, MJ McConnell, B Yu, J Li, JM Balko, EP Black, JO Johnson, ... International journal of oncology 35 (2), 337-345, 2009 | 104 | 2009 |
| ZEB1 mediates acquired resistance to the epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lung cancer T Yoshida, L Song, Y Bai, F Kinose, J Li, KC Ohaegbulam, ... PloS one 11 (1), e0147344, 2016 | 100 | 2016 |
| Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma I Smalley, E Kim, J Li, P Spence, CJ Wyatt, Z Eroglu, VK Sondak, ... EBioMedicine 48, 178-190, 2019 | 94 | 2019 |
| GSK3 alpha and beta are new functionally relevant targets of tivantinib in lung cancer cells LL Remsing Rix, BM Kuenzi, Y Luo, E Remily-Wood, F Kinose, G Wright, ... ACS chemical biology 9 (2), 353-358, 2014 | 93 | 2014 |
| Mass spectrometry mapping of epidermal growth factor receptor phosphorylation related to oncogenic mutations and tyrosine kinase inhibitor sensitivity G Zhang, B Fang, RZ Liu, H Lin, F Kinose, Y Bai, U Oguz, ... Journal of proteome research 10 (1), 305-319, 2011 | 76 | 2011 |
| Linc-ing circulating long non-coding RNAs to the diagnosis and malignant prediction of intraductal papillary mucinous neoplasms of the pancreas JB Permuth, DT Chen, SJ Yoder, J Li, AT Smith, JW Choi, J Kim, ... Scientific reports 7 (1), 10484, 2017 | 69 | 2017 |
| Fragment-based and structure-guided discovery and optimization of Rho kinase inhibitors R Li, MP Martin, Y Liu, B Wang, RA Patel, JY Zhu, N Sun, R Pireddu, ... Journal of medicinal chemistry 55 (5), 2474-2478, 2012 | 67 | 2012 |
| Combined BRAF and HSP90 Inhibition in Patients with Unresectable BRAFV600E-Mutant Melanoma Z Eroglu, YA Chen, GT Gibney, JS Weber, RR Kudchadkar, NI Khushalani, ... Clinical Cancer Research 24 (22), 5516-5524, 2018 | 66 | 2018 |
| Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms J Li, K Bennett, A Stukalov, B Fang, G Zhang, T Yoshida, I Okamoto, ... Molecular systems biology 9 (1), 705, 2013 | 55 | 2013 |
| Characterizing tyrosine phosphorylation signaling in lung cancer using SH2 profiling K Machida, S Eschrich, J Li, Y Bai, J Koomen, BJ Mayer, EB Haura PloS one 5 (10), e13470, 2010 | 49 | 2010 |
| Inhibition of microtubule polymerization by 3-bromopropionylamino benzoylurea (JIMB01), a new cancericidal tubulin ligand JN Li, DQ Song, YH Lin, QY Hu, L Yin, G Bekesi, JF Holland, JD Jiang Biochemical pharmacology 65 (10), 1691-1699, 2003 | 40 | 2003 |
| Double blockade of cell cycle at G1-S transition and M phase by 3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand JD Jiang, L Denner, YH Ling, JN Li, A Davis, Y Wang, Y Li, J Roboz, ... Cancer research 62 (21), 6080-6088, 2002 | 38 | 2002 |
